Strumento inattivo

Azioni Olfactory Biosciences Corp. Other OTC

Azioni

Durata

Periodo

Stile

Olfactory Biosciences Corp. cancelled the transaction announced on May 2, 2017	02/05/18
Olfactory Biosciences Corp. Announces New NOXO Sensory Spectrum Disorders Gel	23/08/17
Olfactory Biosciences Corp. announced that it expects to receive $3 million in funding	02/05/17
OLFY BIOS : OLFC Announces Revolutionary Topical Non-Prescription Natural Medicines for Anxiety, Stress, Sensory issues and Other Common Conditions -- An Answer to Today's Health Care Debacle	15/01/15

Dirigenti	Titolo	Età	Da
Richard Stevenson CEO	Chief Executive Officer	-	-
Sidney J. Pine DFI	Director of Finance/CFO	-	-
Gregory Van Alfen SAM	Sales & Marketing	-	-

Amministratori	Titolo	Età	Da
Sidney J. Pine DFI	Director of Finance/CFO	-	-

Settore